The 3rd CME 2019 “Passing the Baton in Schizophrenia” was a great success. The conference was held at Ameya, Jasola Vihar on 26th May 2019, Sunday. The conference was hosted and organized by PsyCare Neuropsychiatry Care Center.
The conference was attended by more than 40 delegates and focused on key issues relating to the advances in clinical practice in a multidisciplinary team environment. The session included the concept of schizophrenia and its new approaches.
The process of inauguration was commenced in the morning by Dr. Nimesh G Desai, Director at Institute of Human Behavior and Allied Sciences, Col. Sachin Saxena, Senior Adviser (Psychiatry), Base Hospital, Delhi Cant and Dr. Manu Tiwari, Consultant Psychiatrist, Dr, Asif Iqbal Ahmed, Sr. Consultant Psychiatrist at PsyCare and Dr. Ram Ganjoo, Medical Director, PsyCare.
The 2019 program was the biggest and effective with five sequential sessions covering a broad variety of domains related totreatment resistant Schizophrenia- Concept and the Progress, Childhood Schizophrenia- Challenges in Recognising and Managing, latest or new approach for the treatment of schizophrenia, status on rTMS in Schizophrenia and the most important topic Recovery programfollowed by an interactive session moderated by the Founder of PsyCare Hospital Dr. Asif Iqbal Ahmed.
Dr Sandeep Grover, Professor Psychiatry PGIMER, Chandigarh; Dr. Jitender Nagpal, Senior Consultant, Mental Health, Moolchand Medcity, Dr. Shailesh Jha, Dr.Jateen Ukrani, PsyCare and Dr. Ananya Choudhury, PsyCare were the eminent speakers of the Conference who provided candid opinions on the subject matter at hand, making the information extremely valuable.
Overall, the content of the conference was highly appreciated by the delegates. The purpose, results and outcomes were regarded as relevant and meaningful. Furthermore, delegates felt that “the lessons on the case studies of what had worked and what not were very insightful”.
Lastly, we feel that the conference enables the speakers to build networks which enable them to share information and help delegates to utilise the knowledge of others to better understand the issues relating to Schizophrenia. The support of pharmaceutical has added significant value to our conference.